In the reception room of Cross Group, Penny was leading the senior management team for a discussion with Park Sungjun, the CEO of Gemini Group. The two groups were sitting on both sides of the long table, discussing their collaboration.
The Gemini Group was a powerful corporation in the world.
The Cross Group was planning to purchase two hundred million worth of pharmaceutical equipment from The Gemini Group.
Based on Gemini Group's annual sales figure, this was not considered to be a significant deal. However, Park Sungjun took this deal seriously. He even made a trip to Channing personally to discuss about the collaboration, all because he had his eyes on Penny's liver cancer vaccine!
At first glance, Park Sungjun could tell that the liver cancer vaccine was a huge business opportunity. He was willing to sell the two hundred million worth of pharmaceutical equipment to Penny at a low price of only one hundred million.
However, his condition was that Penny had to transfer the overseas manufacturing rights to him.
In other words, the liver cancer vaccine produced by Penny could only be sold in Channing. The markets overseas would all belong to Gemini Group.
Penny knew of the austere terms Gemini Group was bound to impose in exchange for a collaboration.
However, she did not expect Park Sungjun's request to be so excessive.
He actually wanted them to transfer the rights for all overseas markets to the Gemini Group!
This also meant that they could only sell their vaccine in Channing with no opportunity for venturing overseas to globalize their business. He wanted to control the manufacturing rights of the vaccine for the entire world.
Penny said seriously, "Mr. Park, I know that your company's pharmaceutical equipment are very advanced. We hope to purchase the equipment from you. However, your terms are too harsh and I cannot agree to them."
Comments
The readers' comments on the novel: Salute to the General